公司官网显示，2010年，Yod Chinsupakul与大学好友共同创立了Wongnai，这是一个以Yelp为蓝本的餐 厅点评平台。2020年，公司与Line旗下的泰国外卖服务Line Man合并。 2022年，Line Man Wongnai在由新加坡主权财富基金GIC和Naver领投的融资轮中筹集了2.65亿美元，公 司估值超过10亿美元。该公司拥有约1000万月活跃用户，并与70万家餐厅建立了合作关系。 Line Man Wongnai正推进融资计划，旨在加大对其金融科技子公司Lineman Pay的投资。Yod Chinsupakul 表示，公司正押注在线支付普及化，预计此将成盈利增长关键驱动力。他也透露，公司预计将于2025年 首次实现盈利，但未提供具体细节。 报道称，泰国证券交易所正努力应对企业外迁困境，泰国企业寻求在海外获得更雄厚的资本和更高的估 值。对此，泰国监管机构和交易所已推出一系列激励措施，例如放宽上市规则，以留住高增长企业，但 市场低迷、外资流出以及IPO表现不佳，都削弱了曼谷市场的吸引力。 根据泰国证券交易所数据，去年泰国IPO市场融资额约130亿泰铢，为2010年以来最低水平。报 ...

Core Viewpoint - Vingroup's electric mobility service provider, GSM, is considering an overseas IPO with a potential valuation of approximately $20 billion, although no immediate plans for listing are set for 2026 [1] Group 1: IPO Considerations - GSM is working with advisors to evaluate a range of options regarding the IPO [1] - The company emphasizes that any final valuation will largely depend on the timing of the listing and market conditions [1] - Specific details regarding the timeline for the IPO and the exchange location have not been determined [1] Group 2: Financial Expectations - GSM has not disclosed the expected amount of funds it aims to raise through the IPO [1]

Core Viewpoint - Green & Smart Mobility JSC (GSM), a Vietnamese electric vehicle taxi operator, is considering an overseas IPO with a potential valuation of approximately $20 billion, but has confirmed it will not go public before 2026 [1] Company Summary - GSM is controlled by Vietnam's richest individual and is currently collaborating with advisors to evaluate the IPO from multiple perspectives [1] - The company has stated that while it has IPO plans, it will not be listing in 2026, and the final valuation will largely depend on the timing and market conditions at the time of the IPO [1] - GSM has not disclosed the expected fundraising size for the IPO [1]

Core Viewpoint - Muyuan Foods (牧原股份) has made progress in its application for overseas listing of H-shares on the Hong Kong Stock Exchange, receiving a registration notice from the China Securities Regulatory Commission (CSRC) [1] Group 1: Overseas Listing Progress - The company plans to issue no more than 546 million shares for overseas listing and has received a registration notice from the CSRC [1] - The registration notice confirms the company's overseas listing application but does not indicate any judgment on the investment value or returns for investors by the CSRC [1] - The company initiated its Hong Kong listing plan in early 2025 and submitted its application to the Hong Kong Stock Exchange on May 27 [1] Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 111.79 billion yuan, representing a year-on-year growth of 15.52%, and a net profit attributable to shareholders of 14.779 billion yuan, up 41.01% [2] - In the third quarter, the company reported a revenue of 35.327 billion yuan and a net profit of 4.249 billion yuan [2] Group 3: Strategic Partnerships - In August, the company signed a strategic cooperation agreement with Charoen Pokphand Group to enhance collaboration in various sectors including feed, pig farming, slaughtering, and food processing [2] - In September, the company further deepened its business cooperation with BAF Vietnam Agricultural Joint Stock Company, planning to build and operate a high-tech breeding project in Vietnam [2]

Core Viewpoint - Muyuan Foods Co., Ltd. is making significant progress in its overseas listing plans, having received a registration notice from the China Securities Regulatory Commission for its H-share issuance in Hong Kong [1][2]. Group 1: Overseas Listing Progress - The company plans to issue no more than 546 million shares for its overseas listing on the Hong Kong Stock Exchange [1]. - The registration notice requires the company to report any major events during the listing process and to update registration materials if the listing is not completed within 12 months [1][2]. - The company initiated its Hong Kong listing plan in early 2025 and submitted its application on May 27 [1]. Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 111.79 billion yuan, representing a year-on-year growth of 15.52%, and a net profit attributable to shareholders of 14.779 billion yuan, up 41.01% [2]. - In the third quarter, the company reported a revenue of 35.327 billion yuan and a net profit of 4.249 billion yuan [2]. Group 3: Strategic Partnerships - The company signed a strategic cooperation agreement with Charoen Pokphand Group to enhance collaboration in various sectors, including feed, pig farming, and food processing [2]. - In September, the company entered into a partnership with BAF Vietnam Agricultural Joint Stock Company to develop a high-tech pig farming project in Vietnam, with an estimated total investment of 3.2 billion yuan [2].

Core Viewpoint - Hailiang Co., Ltd. plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and international competitiveness [1] Group 1 - The company aims to deepen its globalization strategy and improve its international image [1] - The company is in discussions with relevant intermediaries regarding the H-share issuance and listing [1] - Specific details of the H-share issuance and listing are yet to be finalized [1]

Core Viewpoint - The company, Steady Medical, is currently not prioritizing overseas listing despite the growing trend of A-share companies seeking international capital. The focus remains on domestic growth and market expansion [1][2]. Group 1: Company Strategy - Steady Medical's chairman, Li Jianquan, emphasized that overseas listing is not a current focus, as the domestic market continues to show significant growth potential [1]. - The company previously listed on the US stock market from 2005 to 2012 before returning to the A-share market in September 2020 [1]. Group 2: Financial Performance - For the first half of 2025, Steady Medical reported revenues of 5.296 billion yuan and a net profit attributable to shareholders of 492 million yuan, reflecting year-on-year growth of 31.31% and 28.07%, respectively [2]. - The consumer brand "All Cotton Era" is a key growth driver, generating 2.75 billion yuan in revenue in the first half of 2025, with over 20% year-on-year growth [2]. Group 3: Store Expansion Plans - The annual plan for new stores under "All Cotton Era" has been reduced to 50, down by half from previous projections, due to fewer new commercial real estate projects and a shift towards larger store formats [3]. - The first global flagship store for "All Cotton Era" is set to open in Wuhan, targeting mid-to-high-end consumers and featuring a product range that includes home goods and outdoor apparel [4]. - Future flagship stores are planned for major cities like Beijing, Shanghai, Chengdu, Shenzhen, and Xi'an, with a focus on suitable projects to avoid excessive costs [4].

Core Viewpoint - Nasdaq is proposing stricter listing rules for small companies, particularly targeting Chinese firms, which will significantly impact both businesses and investors seeking alternatives [1][4]. Group 1: Nasdaq's Proposed Changes - The new rules will raise the minimum public float requirement for IPOs from $5 million to $15 million, with a specific requirement of $25 million for new Chinese companies [4]. - Companies failing to meet continued listing standards will face immediate delisting rather than a lengthy appeals process [4]. - The proposed changes are expected to take months for approval by the U.S. Securities and Exchange Commission [4]. Group 2: Impact on Chinese Companies - Chinese companies have seen an average return of -55% in 2024, indicating issues with realistic pricing during IPOs [3]. - The average IPO fundraising for Chinese firms is projected to drop from $300 million in 2021 to $50 million in 2024, influenced by strained U.S.-China relations and increased scrutiny from Chinese regulators [3]. - Companies that cannot meet the new $25 million threshold may seek alternative routes, such as restructuring ownership or considering listings in other financial hubs like Singapore [5]. Group 3: Market Trends and Responses - The number of U.S. listed companies has decreased by 17% over the past three years, with a notable decline of about 50% since 1997 [3]. - Despite challenges, some Chinese IPOs have performed well, such as Ascentage Pharma, which has seen its stock price more than double since its Nasdaq debut [3]. - Smaller companies unable to meet the new requirements may still consider listing on the New York Stock Exchange (NYSE) or pursuing SPAC mergers as an alternative to traditional IPOs [5].

Core Viewpoint - The company has approved the issuance of H-shares and plans to list on the Hong Kong Stock Exchange, which is expected to enhance its core competitiveness and support its strategic expansion plans [1] Group 1: Listing Progress and Impact - The company will comply with relevant laws and regulations and will disclose progress on the issuance and listing in a timely manner [1] - The funds raised from the listing will be primarily used for R&D investments, expansion of manufacturing capacity, and working capital [1] Group 2: Strategic Benefits of Listing - Listing in Hong Kong will help convey the company's core values to the international capital market, enhancing global influence and promoting international business expansion [1] - It will establish an international capital operation platform, strengthening capital strength and facilitating rapid expansion, including future refinancing and overseas mergers and acquisitions [1] - The listing is expected to attract diverse high-quality investors, benefiting the diversification of the company's shareholder structure [1] - The company plans to design various equity incentive schemes through the Hong Kong listing to meet the incentive needs of global talent [1]

Core Insights - A Chinese unicorn company with a valuation exceeding 100 billion faced a delay in its IPO plans in the U.S. due to regulatory policy changes, signaling a warning for other Chinese companies looking to go global [2] - The tightening of overseas listing policies has raised concerns regarding data security, information disclosure, and foreign control, making it crucial for companies to prepare adequately [2][6] Regulatory Environment - Recent years have seen stricter overseas listing policies, with regulatory bodies focusing on financial audits, tax disclosures, and data security as key areas of scrutiny [2][6] - Companies must ensure compliance with financial auditing and tax regulations to maintain transparency in overseas investments and operations [6][12] Risk Management Strategies - Companies are advised to establish overseas company registrations, tax compliance, and international notarization as foundational steps to mitigate policy risks [4][12] - A client successfully optimized international payments through a Hong Kong company and overseas bank accounts, avoiding risks associated with policy changes [5] Financing and Investment Strategies - Delays or obstacles in IPOs can impact financing plans and lead to valuation reductions, highlighting the risks of relying solely on overseas financing or listings [6][8] - Companies should diversify their financing channels, combining overseas listings, offshore bonds, and private equity to spread risk [9] Comprehensive Outbound Strategy - Outbound strategies should encompass not just IPOs or financing but also international trade, brand protection, and tax compliance [8][12] - The recent IPO delay serves as a critical reminder for companies to avoid concentrating their hopes on a single market or business model [8] Recommended Actions - Companies should open overseas bank accounts to ensure liquidity and establish a controlled fund flow system [9][12] - A comprehensive plan should include company registration, bank account setup, financial auditing, tax compliance, and international notarization to ensure operational sustainability [11][12]